Minor salivary gland tumors of the head and neck—Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type

Background Minor salivary gland carcinomas of the head and neck are rare cancers with variable clinical behavior. This study explored the incidence, pathology, clinical behavior, and factors predictive of outcomes in a large cohort of patients treated at Memorial Sloan Kettering Cancer Center over a...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 125; no. 19; pp. 3354 - 3366
Main Authors Hay, Ashley J., Migliacci, Jocelyn, Karassawa Zanoni, Daniella, McGill, Marlena, Patel, Snehal, Ganly, Ian
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Minor salivary gland carcinomas of the head and neck are rare cancers with variable clinical behavior. This study explored the incidence, pathology, clinical behavior, and factors predictive of outcomes in a large cohort of patients treated at Memorial Sloan Kettering Cancer Center over a 30‐year period (1985‐2015). Methods Clinical, pathological, treatment, and outcome data were collected. Unadjusted and adjusted hazard ratios for each variable were calculated with univariate and multivariable Cox regression for survival and recurrence outcomes. Results Four hundred fifty patients were included: 55% were female, 56% were younger than 60 years, and the median follow‐up was 74 months (range, 1‐364 months). The most common site was the oral cavity with 305 tumors (68%), which was followed by the oropharynx with 96 (21%), the sinonasal cavity with 38 (8%), the trachea with 7 (2%), and the larynx with 4 (1%). The most common histological types were mucoepidermoid carcinoma (180 tumors [40%]), adenoid cystic carcinoma (141 tumors [31%]), and polymorphous low‐grade adenocarcinoma (54 tumors [12%]). The 5‐year predicted overall survival rate was 86%, and the disease‐specific survival rate was 94% at 5 years. Pathology and tumor stage were significant variables on multivariate analysis for overall survival, disease‐specific survival, recurrence‐free survival, local recurrence–free survival, regional recurrence–free survival, and distant recurrence–free survival. Conclusions American Joint Committee on Cancer stage and pathology were the most predictive variables across all outcomes. Tumor site, postoperative radiotherapy, and margin status were not statistically significant variables after tumor stage and pathology were controlled for in most outcomes. This is a large retrospective study of 450 minor salivary gland tumors of the head and neck. The tumor stage and histological type are the most predictive variables of survival and recurrence.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author Contributions statement: AJH, SP and IG were responsible for the conception of the work. AJH acquired and performed analysis with substantial contributions from JM, DKZ and MM. AJH, MM, JM, and IG drafted the manuscript, tables and figures. All reviewed final document and approved for publication. AJH and IG are as being responsible for the overall content.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.32208